Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,670.43
(
-0.68%
)
US TECH 100
23,983.60
(
-0.62%
)
Dow Jones
46,545.07
(
-0.95%
)
Brent Oil
104.55
(
3.87%
)
Bitcoin
71,794.05
(
-2.90%
)
News Focus
News Focus

Replies to post #97809 on Biotech Values

Replies to #97809 on Biotech Values
icon url

genisi

06/24/10 2:28 AM

#97821 RE: DewDiligence #97809

This must be bad news for anti-NGF mAb programs. SNY/REGN have an anti-NGF mAb in phase II for osteoarthritis pain.